TNF and vitiligo: While notable GWAS with smaller samples than ours have included those associating genetic variants with vitiligo and response to anti-tumor necrosis factor (anti-TNF) treatment, a larger sample would have enabled us to detect associations with smaller effect sizes (55, 56).